SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares are under pressure amid its boards investigation into CEO Jensen Huangs admitted affair with a businesswoman alleged to have ties to Chinese intelligence, raising speculation about national-security scrutiny and Huangs job security. Traders are split between fearing leadership disruption or further damaging disclosures and viewing the controversy as separate from Nvidias business and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A sharp selloff ahead of Hims & Hers Q3 results has traders debating whether the weakness reflects concern about the report or simply volatile positioning; unverified earnings-leak claims are speculation, not confirmed news. Bulls cite the Eli Lilly obesity-drug partnership and growth prospects, while bears focus on potential margin pressure and the outlook.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep decline alongside a broader crypto selloff has traders focused on whether it will break below the $1 level, with some attributing pressure to market liquidations and uncertainty around crypto regulation and the CLARITY Act. Bearish calls for further losses and frustration over XRPs weak performance compete with holders buying the dip and arguing the token is near a bottom.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is being tied to an Oppenheimer upgrade and Googles use of AMD EPYC processors in its new AI infrastructure, reinforcing the companys data-center growth story. Traders also speculate that Nvidias CEO controversy is prompting a rotation into AMD, though some question the valuation and warn the sharp move could fade.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A sharp, high-volume run-up ahead of Trade Desks Q3 earnings has put the report in focus, with traders speculating about short covering and an unverified earnings leak. Bulls see room for a rebound, while skeptics warn that weak ad-growth expectations could erase the gains and question whether to hold through the release.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

A sharp rally in small caps has put IWM in focus, with traders attributing the move to a possible short squeeze and rotation into the Russell 2000. Bulls welcome the momentum, while skeptics question the rallys light volume and weak inflows and warn it may fade; CPI and Iran-deal speculation add uncertainty.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Twos earnings report ahead of the scheduled GTA VI launch is driving attention, with traders focused on managements guidance and whether it will provide preorder details. Many expect the blockbuster game and its online monetization to boost the business, while others warn that high expectations may already be priced in and the stock could fall on cautious commentary or a sell-the-news reaction.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

AGLT is drawing attention after a sharp post-merger selloff, with traders blaming typical de-SPAC selling and questioning the companys finances, profitability, and valuation ahead of a financial report. Some see the weakness as a chance to accumulate, citing Agilitys humanoid-robot orders and long-term potential, while others remain bearish on the SPAC and its execution risks.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics BRIUMVI growth drove a third-quarter revenue beat and higher full-year guidance, but the share-price pullback despite the results has fueled a sell the news debate. Traders are also focused on Phase 3 data for a subcutaneous BRIUMVI formulation as a future catalyst.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the Nov. 22 PDUFA date and HOPE-3 upper-limb results. Bulls cite the trial data and support from treating physicians, while skeptics emphasize FDA concerns and the risk of a rejection; whether any approval would also cover cardiac benefits remains debated.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IBRX FDA is going to accept the sbla this week and issue a pdufa date of 3 to 6 months. Most likely it&#39;ll be November 9th. Stock will be well over $10 by this Friday. Cheers.

Muddy Waters

FishOn

minestrone

ElectricEel86

Pablo Neruda

Nick

mr mulally

Angelus

pepper heller

Chad

P Reddy

Lindzcav

HeadHunter

JALIB

BUY N HOLD IS DEAD

Chet Hockett

Rod’s Daddy

Gator

Proppa Bear

Not the real Stocktwits

S Olsen

PureLand

Reinhard

George H Holt

FinTruth

Nesta

Abraxis

Dakota Smallwood

Topmost

bigdadneedshoes

StockTwits Web

ImmunityBio Inc

 FDA is going to accept the sbla this week and issue a pdufa date of 3 to 6 months. Most likely it'll be November 9th. Stock will be well over $10 by this Friday. Cheers.